ARCHIVES

Recombinant Protein C Cuts Risk Of Sepsis Death

This article is from The Cancer Letter archive.

Vol. 25 No. 2 | February 22, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

FDA news: Von Eschenbach to FDA staff: “I did not come here to be a figurehead…. While I am here, I will lead.”

November 4, 2005

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

New Cancer Awards Worth $1 Million a Year Announced

September 30, 1988

Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS.

February 15, 2002